$8.66 +0.01 (0.12%)

Teladoc Health, Inc. (TDOC)

Teladoc Health, Inc. is a leading provider of virtual healthcare services, offering telemedicine solutions that enable patients to consult with healthcare professionals remotely. Founded in 2002, the company provides a range of digital health services, including general medical, mental health, and dermatology consultations, aiming to improve access to quality healthcare through technology.

🚫 Teladoc Health, Inc. does not pay dividends

Company News

Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health
The Motley Fool • Prosper Junior Bakiny • October 17, 2025

The article compares two healthcare companies, Iovance Biotherapeutics and Teladoc Health, as potential contrarian investment opportunities. While both companies face challenges, the analysis suggests Teladoc is currently the more attractive option due to its established ecosystem and lower risk profile.

Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarityâ„¢ Monitoring Solution for Hospitals and Health Systems
GlobeNewswire Inc. • Andy Puterbaugh • October 14, 2025

Teladoc Health launched a new AI-enabled workplace safety solution for hospitals that uses video and audio analysis to detect and prevent potential workplace violence, addressing a significant safety challenge in healthcare settings.

Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health
Benzinga • Globe Newswire • August 14, 2025

Teladoc Health has acquired Telecare, an Australian virtual care provider with over 300 specialists across 30 specialties, to expand its international healthcare services and improve access to specialist care in Australia.

Hims & Hers (HIMS) Gains 45.8% in Three Months: What's Next?
Zacks Investment Research • Zacks Investment Research • August 5, 2024

Hims & Hers Health, Inc. (HIMS) has seen a 45.8% stock price increase in the past three months, outperforming the industry and broader market. The company's recent announcements, including the addition of GLP-1 injections to its weight loss portfolio and positive 2024 revenue outlook, have contributed to the stock's upward momentum.

Cathie Wood's ARK adjusts, buys CrowdStrike stock, sells Tesla By Investing.com - Investing.com Canada
Investing.com • Investing.Com • July 23, 2024

Cathie Wood's ARK ETFs made significant portfolio adjustments, selling Teladoc shares, increasing CrowdStrike holdings, and reducing Tesla positions.

Related Companies